GlassScriptPhysician profile
Smeena Khan
NPI 1922108521
$5,408.58
in general payments reported to CMS, 2019-2025
28 companies · $1,700 in 2025
The $1,700 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $416 · 2020: $293 · 2021: $453 · 2022: $788 · 2023: $834 · 2024: $925 · 2025: $1,700.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,368 · Education: $90.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,368.04 |
| Education | $90.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,346.42 | 2019-2025 | |
| Pfizer INC. | $767.95 | 2022-2025 | |
| Galderma Laboratories, L.P. | $684.28 | 2019-2024 | Aklief, Oracea |
| E.R. Squibb & Sons, L.L.C. | $406.09 | 2022-2025 | Sotyktu |
| Arcutis Biotherapeutics, INC. | $256.50 | 2025 | Zoryve |
| Revance Therapeutics, INC. | $248.94 | 2024-2025 | Daxxify |
| Leo Pharma INC. | $206.24 | 2021-2025 | Adbry |
| Lilly USA, LLC | $157.48 | 2023 | Olumiant, Taltz |
| Novartis Pharmaceuticals Corporation | $149.21 | 2021-2024 | |
| Janssen Scientific Affairs, LLC | $142.15 | 2020-2021 | |
| Janssen Biotech, INC. | $140.15 | 2020-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $134.07 | 2020-2025 | Siliq |
| Medimetriks Pharmaceuticals, INC. | $106.23 | 2020-2022 | |
| Organon LLC | $94.98 | 2025 | Vtama |
| Ucb, INC. | $90.21 | 2020-2023 | Cimzia, Bimzelx |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $72.14 | 2023-2025 | Opzelura, Opzelura |
| Regeneron Healthcare Solutions, INC. | $66.38 | 2019-2024 | Libtayo, Dupixent |
| Strata Skin Sciences, INC. | $54.98 | 2021 | |
| Merz North America, INC. | $40.87 | 2022 | |
| Sun Pharmaceutical Industries INC. | $39.86 | 2022-2024 | |
| Encore Dermatology INC. | $37.53 | 2019 | |
| Botanix Sb INC | $33.61 | 2025 | Sofdra |
| Epi Health, LLC | $32.75 | 2020-2021 | |
| Aclaris Therapeutics, INC. | $23.68 | 2019 | |
| Kyowa Kirin, INC. | $23.50 | 2023 | Poteligeo |
| Ani Pharmaceuticals, INC. | $21.20 | 2022 | |
| Almirall LLC | $20.08 | 2022 | |
| Vyne Pharmaceuticals INC. | $11.10 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Smeena Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.